Figures & data
Figure 1 Strategies for screening patients with AECOPD.
![Figure 1 Strategies for screening patients with AECOPD.](/cms/asset/ce14ff0a-ade7-4227-a501-02d8bbf15fc2/dcop_a_92160_f0001_b.jpg)
Table 1 Baseline characteristics, clinical features at study entry, and outcomes in 81 patients with COPD exacerbation
Figure 2 Viruses detected by RVP kit from the nasopharyngeal samples of 81 patients admitted for AECOPD were influenza virus (n=21), enterovirus/rhinovirus (n=11), coronavirus (n=9), bocavirus (n=6), metapneumovirus (n=5), parainfluenza virus types 1, 2, 3, and 4 (n=3), and RSV (n=3).
![Figure 2 Viruses detected by RVP kit from the nasopharyngeal samples of 81 patients admitted for AECOPD were influenza virus (n=21), enterovirus/rhinovirus (n=11), coronavirus (n=9), bocavirus (n=6), metapneumovirus (n=5), parainfluenza virus types 1, 2, 3, and 4 (n=3), and RSV (n=3).](/cms/asset/0b1d997e-f81f-4d5a-9a29-43df62e3d15c/dcop_a_92160_f0002_b.jpg)
Figure 3 Statistical distribution (box plot) of LOS according to the four respiratory infectious phenotypes: 0 – non-infectious group, 1 – viral infection, 2 – bacterial infection, 3 – coinfection.
Abbreviation: LOS, length of stay.
![Figure 3 Statistical distribution (box plot) of LOS according to the four respiratory infectious phenotypes: 0 – non-infectious group, 1 – viral infection, 2 – bacterial infection, 3 – coinfection.](/cms/asset/3237c007-867d-45e9-9941-06940056ad7e/dcop_a_92160_f0003_b.jpg)